T-cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.

已完结 10 由 121 发布于 2026/8/14 21:36:49

DOI:10.1016/j.ymthe.2026.03.012
作者：Xiongfei Xu,Haihui Gu,Zhanshan Cha,Bin Zhang,Shuai Yuan,Xiuwen Ding,Lei Gao,Suizhi Gao,Xinqian Wu,Lingyun Gu,Jianye Huang,Jianling Hao,Penghao Li,Yikai Li,Xiaochao Kang,Xiaohan Shi,Xiaoyi Yin,Huan Wan
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Adoptive T-cell transfer targeting KRAS G12D can induce tumor regression in advanced epithelial cancers. The safety, efficacy of TCR-T cells targeting KRAS G12V, and potential benefit of rep

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureA federated graph learning method to realize multi-party collaboration for molecular discovery